Literature DB >> 24840884

Disorders of aldosterone synthesis, secretion, and cellular function.

Allen W Root1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to describe the renin-angiotensin-aldosterone system and its regulatory control of sodium, potassium, chloride, hydrogen ion, and water homeostasis through its effects on the expression and activity of distal renal tubular cotransporter proteins and to discuss the gene mutations encoding these structures that disturb the function of this system. RECENT
FINDINGS: Primary hypoaldosteronism may be the result of acquired or congenital errors in renal juxtaglomerular function (the source of renin), angiotensin generation or activity, or aldosterone synthesis. Secondary hypoaldosteronism (pseudohypoaldosteronism) occurs as a consequence of mutations in genes encoding the mineralocorticoid receptor (MR), the three subunits of the aldosterone-responsive, amiloride-sensitive nonvoltage-gated sodium channel encoded by SCNN1A, SCNN1B, and SCNN1G, the gene that regulates posttranslational phosphorylation (encoded by WNK4) of the thiazide-sensitive sodium chloride cotransporter encoded by SLC12A3, and those that regulate phosphorylation and ubiquitination of cofactors encoded by WNK1, KLH3, and CUL3 that affect WNK4 function.
SUMMARY: Acquired disorders of renal function as well as mutations in many genes may adversely affect aldosterone-mediated mineral homeostasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24840884     DOI: 10.1097/MOP.0000000000000104

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  6 in total

Review 1.  Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management.

Authors:  André Gustavo P Sousa; João Victor de Sousa Cabral; William Batah El-Feghaly; Luísa Silva de Sousa; Adriana Bezerra Nunes
Journal:  World J Diabetes       Date:  2016-03-10

2.  Dermal and Ophthalmic Findings in Pseudohypoaldosteronism.

Authors:  Sabriye Korkut; Emir Gökalp; Ahmet Özdemir; Selim Kurtoğlu; Şafak Demirtaş; Ülkü Gül; Osman Baştuğ
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

Review 3.  Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

Authors:  Vincenzo Salpietro; Agata Polizzi; Gabriella Di Rosa; Anna Claudia Romeo; Valeria Dipasquale; Paolo Morabito; Valeria Chirico; Teresa Arrigo; Martino Ruggieri
Journal:  Int J Endocrinol       Date:  2014-09-03       Impact factor: 3.257

4.  Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience.

Authors:  Carla Bizzarri; Nicole Olivini; Stefania Pedicelli; Romana Marini; Germana Giannone; Paola Cambiaso; Marco Cappa
Journal:  Ital J Pediatr       Date:  2016-08-02       Impact factor: 2.638

5.  Aldosterone Modulates the Association between NCC and ENaC.

Authors:  Brandi M Wynne; Abinash C Mistry; Otor Al-Khalili; Rickta Mallick; Franziska Theilig; Douglas C Eaton; Robert S Hoover
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

6.  Aldosterone signaling defect in young infants: single-center report and review.

Authors:  Melati Wijaya; Huamei Ma; Jun Zhang; Minlian Du; Yanhong Li; Qiuli Chen; Song Guo
Journal:  BMC Endocr Disord       Date:  2021-07-09       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.